Correction of glycosylated oxyhemoglobin-induced impairment of endothelium-dependent vasodilatation by gliclazide

This publication has 18 references indexed in Scilit:

• The effects of gliclazide and other sulfonylureas on low-density lipoprotein oxidation in vitro
  Metabolism, 1997
• Microvascular permeability with sulfonylureas in normal and diabetic hamsters
  Metabolism, 1997
• Gliclazide decreases cell-mediated low-density lipoprotein (LDL) oxidation and reduces monocyte adhesion to endothelial cells induced by oxidatively modified LDL
  Metabolism, 1997
• Impairment of Endothelium-Dependent Relaxation by Increasing Percentages of Glycosylated Human Hemoglobin
  Hypertension, 1996
• Effects of gliclazide on platelet reactivity and free radicals in type II diabetic patients: Clinical assessment
  Metabolism, 1992
• Mechanistic studies of advanced glycosylation end product inhibition by aminoguanidine
  Diabetes, 1992
• The mode of action and clinical pharmacology of gliclazide: a review
  Diabetes Research and Clinical Practice, 1991
• Free radical generation by early glycation products: A mechanism for accelerated atherogenesis in diabetes
  Biochemical and Biophysical Research Communications, 1990
• [41] Preparation and assay of superioxide dismutases
  Published by Elsevier ,1978
• Contractile properties of small arterial resistance vessels in spontaneously hypertensive and normotensive rats.
  Circulation Research, 1977